Mabwell(SH:688062) Zheng Quan Zhi Xing·2025-08-05 16:20Core Viewpoint - The company, Maiwei (Shanghai) Biotechnology Co., Ltd., has announced a share repurchase plan aimed at utilizing the repurchased shares for employee stock ownership plans or equity incentives, with a total expected repurchase amount between 25 million to 50 million RMB [1][2]. Group 1: Share Repurchase Plan - The share repurchase plan was first disclosed on June 27, 2025, and the implementation period is from June 26, 2025, to June 25, 2026 [1]. - The company plans to repurchase shares using its own funds and/or a special loan for stock repurchase through the Shanghai Stock Exchange trading system [1]. - The maximum repurchase price is not to exceed a specified amount, and the total number of shares repurchased will be reported monthly [2]. Group 2: Progress of Share Repurchase - As of July 31, 2025, the company has not yet implemented the share repurchase plan and will choose the timing based on market conditions [2]. - The company is committed to adhering to relevant regulations during the repurchase period and will disclose progress in a timely manner [2].